450 related articles for article (PubMed ID: 16964963)
1. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
5. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin levels in overweight and obese Asians.
Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
Obes Res; 2002 Nov; 10(11):1104-10. PubMed ID: 12429873
[TBL] [Abstract][Full Text] [Related]
8. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
10. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
11. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
[TBL] [Abstract][Full Text] [Related]
13. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
15. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
17. Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals.
Francischetti EA; Celoria BM; Duarte SF; da Silva EG; Santos IJ; Cabello PH; Genelhu VA
Metabolism; 2007 Nov; 56(11):1464-9. PubMed ID: 17950095
[TBL] [Abstract][Full Text] [Related]
18. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
19. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.
Cizmecioglu FM; Etiler N; Ergen A; Gormus U; Keser A; Hekim N; Hamzaoglu O; Hatun S
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans.
Merl V; Peters A; Oltmanns KM; Kern W; Born J; Fehm HL; Schultes B
Int J Obes (Lond); 2005 Aug; 29(8):998-1001. PubMed ID: 15917861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
